248 related articles for article (PubMed ID: 24164289)
1. Identification and characterization of novel surfactins produced by fungal antagonist Bacillus amyloliquefaciens 6B.
Pathak KV; Bose A; Keharia H
Biotechnol Appl Biochem; 2014; 61(3):349-56. PubMed ID: 24164289
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization and identification of cyclic lipopeptides produced by Bacillus methylotrophicus DCS1 strain.
Jemil N; Manresa A; Rabanal F; Ben Ayed H; Hmidet N; Nasri M
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():374-386. PubMed ID: 28666229
[TBL] [Abstract][Full Text] [Related]
3. Ion trap mass spectrometry of surfactins produced by Bacillus subtilis SZMC 6179J reveals novel fragmentation features of cyclic lipopeptides.
Bóka B; Manczinger L; Kecskeméti A; Chandrasekaran M; Kadaikunnan S; Alharbi NS; Vágvölgyi C; Szekeres A
Rapid Commun Mass Spectrom; 2016 Jul; 30(13):1581-90. PubMed ID: 27321846
[TBL] [Abstract][Full Text] [Related]
4. The plant-associated Bacillus amyloliquefaciens strains MEP2 18 and ARP2 3 capable of producing the cyclic lipopeptides iturin or surfactin and fengycin are effective in biocontrol of sclerotinia stem rot disease.
Alvarez F; Castro M; Príncipe A; Borioli G; Fischer S; Mori G; Jofré E
J Appl Microbiol; 2012 Jan; 112(1):159-74. PubMed ID: 22017648
[TBL] [Abstract][Full Text] [Related]
5. [Isolation and identification of lipopeptides produced by Bacillus subtilis using high performance liquid chromatography and electrospray ionization mass spectrometry].
Chen H; Wang L; Yuan C; Zheng Z; Yu Z
Se Pu; 2008 May; 26(3):343-7. PubMed ID: 18724673
[TBL] [Abstract][Full Text] [Related]
6. Effects of different amino acids in culture media on surfactin variants produced by Bacillus subtilis TD7.
Liu JF; Yang J; Yang SZ; Ye RQ; Mu BZ
Appl Biochem Biotechnol; 2012 Apr; 166(8):2091-100. PubMed ID: 22415784
[TBL] [Abstract][Full Text] [Related]
7. A sensitive method for simultaneous quantitative determination of surfactin and iturin by LC-MS/MS.
Deng Q; Wang W; Sun L; Wang Y; Liao J; Xu D; Liu Y; Ye R; Gooneratne R
Anal Bioanal Chem; 2017 Jan; 409(1):179-191. PubMed ID: 27766360
[TBL] [Abstract][Full Text] [Related]
8. ESI LC-MS and MS/MS characterization of antifungal cyclic lipopeptides produced by Bacillus subtilis XF-1.
Li XY; Mao ZC; Wang YH; Wu YX; He YQ; Long CL
J Mol Microbiol Biotechnol; 2012; 22(2):83-93. PubMed ID: 22614917
[TBL] [Abstract][Full Text] [Related]
9. LC/ESI-MS/MS characterisation of lipopeptide biosurfactants produced by the Bacillus licheniformis V9T14 strain.
Pecci Y; Rivardo F; Martinotti MG; Allegrone G
J Mass Spectrom; 2010 Jul; 45(7):772-8. PubMed ID: 20623484
[TBL] [Abstract][Full Text] [Related]
10. Antifungal lipopeptides from Bacillus amyloliquefaciens strain BO7.
Romano A; Vitullo D; Di Pietro A; Lima G; Lanzotti V
J Nat Prod; 2011 Feb; 74(2):145-51. PubMed ID: 21235220
[TBL] [Abstract][Full Text] [Related]
11. Isolation and structural analysis of bamylocin A, novel lipopeptide from Bacillus amyloliquefaciens LP03 having antagonistic and crude oil-emulsifying activity.
Lee SC; Kim SH; Park IH; Chung SY; Choi YL
Arch Microbiol; 2007 Oct; 188(4):307-12. PubMed ID: 17530228
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of surfactin produced by Bacillus polyfermenticus KJS-2.
Kim KM; Lee JY; Kim CK; Kang JS
Arch Pharm Res; 2009 May; 32(5):711-5. PubMed ID: 19471885
[TBL] [Abstract][Full Text] [Related]
13. Antifungal cyclic lipopeptides from Bacillus amyloliquefaciens strain BO5A.
Romano A; Vitullo D; Senatore M; Lima G; Lanzotti V
J Nat Prod; 2013 Nov; 76(11):2019-25. PubMed ID: 24164115
[TBL] [Abstract][Full Text] [Related]
14. Effects of Different Cultivation Parameters on the Production of Surfactin Variants by a
Bartal A; Vigneshwari A; Bóka B; Vörös M; Takács I; Kredics L; Manczinger L; Varga M; Vágvölgyi C; Szekeres A
Molecules; 2018 Oct; 23(10):. PubMed ID: 30340314
[TBL] [Abstract][Full Text] [Related]
15. Characterization of fungal antagonistic bacilli isolated from aerial roots of banyan (Ficus benghalensis) using intact-cell MALDI-TOF mass spectrometry (ICMS).
Pathak KV; Keharia H
J Appl Microbiol; 2013 May; 114(5):1300-10. PubMed ID: 23387377
[TBL] [Abstract][Full Text] [Related]
16. In situ detection of the intermediates in the biosynthesis of surfactin, a lipoheptapeptide from Bacillus subtilis OKB 105, by whole-cell cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in combination with mutant analysis.
Vater J; Wilde C; Kell H
Rapid Commun Mass Spectrom; 2009 May; 23(10):1493-8. PubMed ID: 19350532
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the antifungal lipopeptide iturin A by high performance liquid chromatography coupled with aqueous two-phase extraction.
Yuan J; Raza W; Huang Q; Shen Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2746-50. PubMed ID: 21872538
[TBL] [Abstract][Full Text] [Related]
18. NMR spectroscopic and MS/MS spectrometric characterization of a new lipopeptide antibiotic bacillopeptin B1 produced by a marine sediment-derived Bacillus amyloliquefaciens SH-B74.
Ma Z; Hu J; Wang X; Wang S
J Antibiot (Tokyo); 2014 Feb; 67(2):175-8. PubMed ID: 24064466
[No Abstract] [Full Text] [Related]
19. Identification of surfactins and iturins produced by potent fungal antagonist, Bacillus subtilis K1 isolated from aerial roots of banyan (Ficus benghalensis) tree using mass spectrometry.
Pathak KV; Keharia H
3 Biotech; 2014 Jun; 4(3):283-295. PubMed ID: 28324431
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity and spectroscopic characterization of surfactin class of lipopeptides from Bacillus amyloliquefaciens SR1.
Nanjundan J; Ramasamy R; Uthandi S; Ponnusamy M
Microb Pathog; 2019 Mar; 128():374-380. PubMed ID: 30695712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
